$NXPT
Nexpoint Capital Inc Stock $nxpt

$nxpt Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-K Financial Statement

#000119312523079332 Filed on March 27, 2023

Income Statement

Concept	2022 Q4	2022 Q3	2022 Q2
Revenue	$113.6K	$555.6K	$629.3K
YoY Change	-5253.33%	-34.4%	17.8%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses		$562.7K	$569.6K
YoY Change
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net		$36.08K	$26.15K
YoY Change
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings	$370.7K	-$2.653M	-$2.928M
YoY Change
Net Earnings / Revenue	326.24%	-477.43%	-465.36%
Basic Earnings Per Share	$0.04	$0.27	$0.29
Diluted Earnings Per Share	$0.04	$0.27	$0.29
COMMON SHARES
Basic Shares Outstanding	9.678M	9.882M	9.949M
Diluted Shares Outstanding		9.882M	9.949M

Balance Sheet

Concept	2022 Q4	2022 Q3	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$1.630M	$2.174M	$3.527M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$2.422M
YoY Change	-64.83%
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$55.25M
YoY Change	-14.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities	$1.558M
YoY Change	-5.49%
SHAREHOLDERS EQUITY
Retained Earnings	-$33.26M
YoY Change	17.93%
Common Stock	$9.678K
YoY Change	-2.79%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$53.69M
YoY Change
Total Liabilities & Shareholders Equity
YoY Change

Cashflow Statement

Concept	2022 Q4	2022 Q3	2022 Q2
OPERATING ACTIVITIES
Net Income	$370.7K	-$2.653M	-$2.928M
YoY Change
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001588272
CY2022Q4	dei	Entity Public Float EntityPublicFloat	0
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	814-01074
CY2022	dei	Entity Registrant Name EntityRegistrantName	NexPoint Capital, Inc.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	38-3926499
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	300 Crescent Court
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 700
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Dallas
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75201
CY2022	dei	City Area Code CityAreaCode	972
CY2022	dei	Local Phone Number LocalPhoneNumber	628-4100
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	false
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	9677593
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1629846
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2811171
CY2022Q4	us-gaap	Securities Purchased Under Agreements To Resell SecuritiesPurchasedUnderAgreementsToResell	0
CY2021Q4	us-gaap	Securities Purchased Under Agreements To Resell SecuritiesPurchasedUnderAgreementsToResell	990537
CY2022Q4	cik0001588272	Dividends And Interest Receivable DividendsAndInterestReceivable	220194
CY2021Q4	cik0001588272	Dividends And Interest Receivable DividendsAndInterestReceivable	440404
CY2022Q4	us-gaap	Due From Related Parties DueFromRelatedParties	92216
CY2021Q4	us-gaap	Due From Related Parties DueFromRelatedParties	95458
CY2022Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	15905
CY2021Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	13222
CY2022Q4	us-gaap	Assets Assets	55251876
CY2021Q4	us-gaap	Assets Assets	64587103
CY2022Q4	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase
CY2021Q4	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	301369
CY2022Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	314993
CY2021Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	378587
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	371736
CY2021Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	72178
CY2022Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	870980
CY2021Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	896061
CY2022Q4	us-gaap	Liabilities Liabilities	1557709
CY2021Q4	us-gaap	Liabilities Liabilities	1648195
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9677593
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9677593
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9956228
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9956228
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	9678
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	9956
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	86949376
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	91135719
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-33264887
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-28206767
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	53694167
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	62938908
CY2022Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	5.55
CY2021Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	6.32
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	2178971
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	3070371
CY2020	us-gaap	Investment Income Interest InvestmentIncomeInterest	3288205
CY2022	cik0001588272	Payment In Kind Interest Income PaymentInKindInterestIncome	193003
CY2021	cik0001588272	Payment In Kind Interest Income PaymentInKindInterestIncome	100908
CY2020	cik0001588272	Payment In Kind Interest Income PaymentInKindInterestIncome	400250
CY2021	us-gaap-supplement	Fee Income FeeIncome	4651
CY2020	us-gaap-supplement	Fee Income FeeIncome	108535
CY2022	us-gaap	Gross Investment Income Operating GrossInvestmentIncomeOperating	3692613
CY2021	us-gaap	Gross Investment Income Operating GrossInvestmentIncomeOperating	4097859
CY2020	us-gaap	Gross Investment Income Operating GrossInvestmentIncomeOperating	4813182
CY2022	us-gaap	Noninterest Expense Investment Advisory Fees NoninterestExpenseInvestmentAdvisoryFees	1096487
CY2021	us-gaap	Noninterest Expense Investment Advisory Fees NoninterestExpenseInvestmentAdvisoryFees	1220044
CY2020	us-gaap	Noninterest Expense Investment Advisory Fees NoninterestExpenseInvestmentAdvisoryFees	1192535
CY2022	cik0001588272	Custodian And Accounting Service Fees CustodianAndAccountingServiceFees	311050
CY2021	cik0001588272	Custodian And Accounting Service Fees CustodianAndAccountingServiceFees	307438
CY2020	cik0001588272	Custodian And Accounting Service Fees CustodianAndAccountingServiceFees	312199
CY2022	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	226948
CY2021	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	244754
CY2020	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	245534
CY2022	us-gaap	Investment Company Shareholder Service Fee Expense InvestmentCompanyShareholderServiceFeeExpense	209866
CY2021	us-gaap	Investment Company Shareholder Service Fee Expense InvestmentCompanyShareholderServiceFeeExpense	208251
CY2020	us-gaap	Investment Company Shareholder Service Fee Expense InvestmentCompanyShareholderServiceFeeExpense	248563
CY2022	cik0001588272	Audit And Tax Fees AuditAndTaxFees	167864
CY2021	cik0001588272	Audit And Tax Fees AuditAndTaxFees	168254
CY2020	cik0001588272	Audit And Tax Fees AuditAndTaxFees	223648
CY2022	us-gaap	Other Expenses OtherExpenses	113825
CY2021	us-gaap	Other Expenses OtherExpenses	155670
CY2020	us-gaap	Other Expenses OtherExpenses	10799
CY2022	cik0001588272	Reports To Stockholders ReportsToStockholders	82721
CY2021	cik0001588272	Reports To Stockholders ReportsToStockholders	75060
CY2020	cik0001588272	Reports To Stockholders ReportsToStockholders	82492
CY2022	us-gaap	Legal Fees LegalFees	53658
CY2021	us-gaap	Legal Fees LegalFees	72441
CY2020	us-gaap	Legal Fees LegalFees	81141
CY2022	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	18170
CY2021	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	17781
CY2020	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	20123
CY2020	us-gaap	Interest Expense InterestExpense	176707
CY2022	us-gaap	Operating Expenses OperatingExpenses	2280589
CY2021	us-gaap	Operating Expenses OperatingExpenses	2469693
CY2020	us-gaap	Operating Expenses OperatingExpenses	2593741
CY2022	cik0001588272	Expenses Waived Or Recouped By Adviser ExpensesWaivedOrRecoupedByAdviser	377594
CY2021	cik0001588272	Expenses Waived Or Recouped By Adviser ExpensesWaivedOrRecoupedByAdviser	295261
CY2020	cik0001588272	Expenses Waived Or Recouped By Adviser ExpensesWaivedOrRecoupedByAdviser	349488
CY2022	cik0001588272	Operating Expenses Net OperatingExpensesNet	1902995
CY2021	cik0001588272	Operating Expenses Net OperatingExpensesNet	2174432
CY2020	cik0001588272	Operating Expenses Net OperatingExpensesNet	2244253
CY2022	us-gaap	Net Investment Income NetInvestmentIncome	1789618
CY2021	us-gaap	Net Investment Income NetInvestmentIncome	1923427
CY2020	us-gaap	Net Investment Income NetInvestmentIncome	2568929
CY2020	cik0001588272	Net Realized Gain Loss On Total Return Swaps NetRealizedGainLossOnTotalReturnSwaps	-6929996
CY2020	cik0001588272	Net Change In Unrealized Appreciation Depreciation On Investment NetChangeInUnrealizedAppreciationDepreciationOnInvestment	2745042
CY2022	us-gaap	Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency	-5854792
CY2021	us-gaap	Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency	3782716
CY2020	us-gaap	Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency	-23468207
CY2022	us-gaap	Investment Company Net Assets From Operations Increase Decrease InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease	-4065174
CY2021	us-gaap	Investment Company Net Assets From Operations Increase Decrease InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease	5706143
CY2020	us-gaap	Investment Company Net Assets From Operations Increase Decrease InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease	-20899278
CY2022	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	0.18
CY2021	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	0.19
CY2020	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	0.24
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.41
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.41
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.56
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.56
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.98
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.98
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9893732
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9893732
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10254666
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10254666
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10525271
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10525271
CY2019Q4	us-gaap	Assets Net AssetsNet	88935553
CY2020	us-gaap	Investment Income Net InvestmentIncomeNet	2568929
CY2020	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-20436938
CY2020	cik0001588272	Net Realized Gain Loss On Total Return Swaps NetRealizedGainLossOnTotalReturnSwaps	-6929996
CY2020	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	1153685
CY2020	cik0001588272	Net Change In Unrealized Appreciation Depreciation NetChangeInUnrealizedAppreciationDepreciation	2745042
CY2020	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1301163
CY2020	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	1864760
CY2020	us-gaap	Investment Company Dividend Distribution InvestmentCompanyDividendDistribution	4409400
CY2020	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	-24745081
CY2020Q4	us-gaap	Assets Net AssetsNet	64190472
CY2020	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	0.42
CY2020Q4	us-gaap	Shares Outstanding SharesOutstanding	10475168
CY2020Q4	us-gaap	Assets Net AssetsNet	64190472
CY2021	us-gaap	Investment Income Net InvestmentIncomeNet	1923427
CY2021	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-3479546
CY2021	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	7262262
CY2021	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	727993
CY2021	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	4643769
CY2021	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	209053
CY2021	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	1319241
CY2021	us-gaap	Investment Company Dividend Distribution InvestmentCompanyDividendDistribution	3633179
CY2021	us-gaap	Stock Issued During Period Shares Period Increase Decrease StockIssuedDuringPeriodSharesPeriodIncreaseDecrease	-518940
CY2021	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-155884
CY2020	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-150143
CY2020	cik0001588272	Increase Decrease In Payable On Total Return Swap IncreaseDecreaseInPayableOnTotalReturnSwap	-11458
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4023323
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	9086115
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	31310408
CY2021	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	-1251564
CY2021Q4	us-gaap	Shares Outstanding SharesOutstanding	9956228
CY2021Q4	us-gaap	Assets Net AssetsNet	62938908
CY2021	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	0.36
CY2021Q4	us-gaap	Assets Net AssetsNet	62938908
CY2022	us-gaap	Investment Income Net InvestmentIncomeNet	1789618
CY2022	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	329081
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-6183873
CY2022	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	2862936
CY2022	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	1209200
CY2022	us-gaap	Investment Company Dividend Distribution InvestmentCompanyDividendDistribution	1526458
CY2022	us-gaap	Investment Company Tax Return Of Capital Distribution InvestmentCompanyTaxReturnOfCapitalDistribution	1999373
CY2022	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	-9244741
CY2022Q4	us-gaap	Assets Net AssetsNet	53694167
CY2022	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	0.36
CY2022	us-gaap	Profit Loss ProfitLoss	4065174
CY2021	us-gaap	Profit Loss ProfitLoss	-5706143
CY2020	us-gaap	Profit Loss ProfitLoss	20899278
CY2022	cik0001588272	Purchases Of Investment Securities PurchasesOfInvestmentSecurities	-9519074
CY2021	cik0001588272	Purchases Of Investment Securities PurchasesOfInvestmentSecurities	-8119981
CY2020	cik0001588272	Purchases Of Investment Securities PurchasesOfInvestmentSecurities	-54511342
CY2022	cik0001588272	Payment In Kind Investments PaymentInKindInvestments	193003
CY2021	cik0001588272	Payment In Kind Investments PaymentInKindInvestments	100908
CY2020	cik0001588272	Payment In Kind Investments PaymentInKindInvestments	400250
CY2022	cik0001588272	Proceeds From Sales And Principal Repayments Of Investment Securities ProceedsFromSalesAndPrincipalRepaymentsOfInvestmentSecurities	11143514
CY2021	cik0001588272	Proceeds From Sales And Principal Repayments Of Investment Securities ProceedsFromSalesAndPrincipalRepaymentsOfInvestmentSecurities	17408129
CY2020	cik0001588272	Proceeds From Sales And Principal Repayments Of Investment Securities ProceedsFromSalesAndPrincipalRepaymentsOfInvestmentSecurities	72368347
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-6183873
CY2021	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	7262262
CY2020	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	1153685
CY2022	cik0001588272	Net Change In Unrealized Appreciation Depreciation NetChangeInUnrealizedAppreciationDepreciation	-2745042
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	-343633
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	-972220
CY2020	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	-980931
CY2022	cik0001588272	Increase Decrease In Receivable For Investments Sold IncreaseDecreaseInReceivableForInvestmentsSold	990537
CY2021	cik0001588272	Increase Decrease In Receivable For Investments Sold IncreaseDecreaseInReceivableForInvestmentsSold	-990537
CY2020	cik0001588272	Increase Decrease In Receivable For Investments Sold IncreaseDecreaseInReceivableForInvestmentsSold	0
CY2022	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	-220210
CY2021	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	155192
CY2020	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	-756893
CY2022	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	-3242
CY2021	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	-6084
CY2020	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	51412
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	2683
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	13222
CY2020	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-12208
CY2020	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	-21400000
CY2022	cik0001588272	Increase Decrease In Payable For Investments Purchased IncreaseDecreaseInPayableForInvestmentsPurchased	-301369
CY2021	cik0001588272	Increase Decrease In Payable For Investments Purchased IncreaseDecreaseInPayableForInvestmentsPurchased	301369
CY2020	cik0001588272	Increase Decrease In Payable For Investments Purchased IncreaseDecreaseInPayableForInvestmentsPurchased	-2533314
CY2022	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	-63594
CY2021	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	-44950
CY2020	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	-146916
CY2020	cik0001588272	Increase Decrease In Interest Expense And Commitment Fees Payable IncreaseDecreaseInInterestExpenseAndCommitmentFeesPayable	-80207
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	299558
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2862936
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	4643769
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2403568
CY2022	us-gaap	Payments Of Dividends PaymentsOfDividends	2341712
CY2021	us-gaap	Payments Of Dividends PaymentsOfDividends	2360642
CY2020	us-gaap	Payments Of Dividends PaymentsOfDividends	2227401
CY2020	cik0001588272	Decrease In Credit Facilities Payable DecreaseInCreditFacilitiesPayable	-40971777
CY2020	cik0001588272	Increase In Credit Facilities Payable IncreaseInCreditFacilitiesPayable	7256913
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-5204648
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-7004411
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-38345833
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1181325
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2081704
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-7035425
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2811171
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	729467
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7764892
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1629846
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2811171
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	729467
CY2022	us-gaap	Interest Paid Net InterestPaidNet	193003
CY2021	us-gaap	Interest Paid Net InterestPaidNet	100908
CY2020	us-gaap	Interest Paid Net InterestPaidNet	400250
CY2020	us-gaap	Interest Paid Discontinued Operations InterestPaidDiscontinuedOperations	256914
CY2022	cik0001588272	Reinvestment Of Distributions Paid ReinvestmentOfDistributionsPaid	1209200
CY2021	cik0001588272	Reinvestment Of Distributions Paid ReinvestmentOfDistributionsPaid	1319241
CY2020	cik0001588272	Reinvestment Of Distributions Paid ReinvestmentOfDistributionsPaid	1864760
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	36426
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	87200
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	47000
CY2022Q4	us-gaap	Assets Net AssetsNet	53694167
CY2022Q4	cik0001588272	Percentage Of Non Qualifying Asset On Companys Total Asset PercentageOfNonQualifyingAssetOnCompanysTotalAsset	0.048
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	2421875
CY2022Q4	cik0001588272	Percentage Of Net Assets Under Valuation Procedure PercentageOfNetAssetsUnderValuationProcedure	0.045
CY2021Q4	us-gaap	Assets Net AssetsNet	62938908
CY2021Q4	cik0001588272	Percentage Of Non Qualifying Asset On Companys Total Asset PercentageOfNonQualifyingAssetOnCompanysTotalAsset	0.148
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	6885360
CY2021Q4	cik0001588272	Percentage Of Net Assets Under Valuation Procedure PercentageOfNetAssetsUnderValuationProcedure	0.109
CY2021Q4	cik0001588272	Investment Acquistion Date InvestmentAcquistionDate	2020-12-07
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	10000000
CY2022	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	2549002
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: "Times New Roman";"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Use of Estimates </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of increases and decreases in net assets from operations during the reporting period. Actual results could differ from those estimates. </div>
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1629846
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2811171
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	209418
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	106978
CY2021Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	60236311
CY2021Q4	cik0001588272	Investment Owned Percentage Of Total Assets InvestmentOwnedPercentageOfTotalAssets	1
CY2022Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	54011971
CY2021Q4	us-gaap	Financial Instruments Sold Not Yet Purchased At Fair Value FinancialInstrumentsSoldNotYetPurchasedAtFairValue	0
CY2022Q4	us-gaap	Financial Instruments Sold Not Yet Purchased At Fair Value FinancialInstrumentsSoldNotYetPurchasedAtFairValue	0
CY2022Q4	us-gaap	Investment Sold Not Yet Purchased Percent Of Net Assets InvestmentSoldNotYetPurchasedPercentOfNetAssets	0.25
CY2021Q4	us-gaap	Investment Sold Not Yet Purchased Percent Of Net Assets InvestmentSoldNotYetPurchasedPercentOfNetAssets	0.25
CY2022	us-gaap-supplement	Fee Income FeeIncome	0
CY2021	us-gaap-supplement	Fee Income FeeIncome	4651
CY2020	us-gaap-supplement	Fee Income FeeIncome	108535
CY2022Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	53293715
CY2022Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	53293715
CY2021Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	60236311
CY2021Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	60236311
CY2021Q4	us-gaap	Fair Value Disclosure Offbalance Sheet Risks Amount Asset FairValueDisclosureOffbalanceSheetRisksAmountAsset	0
CY2022Q4	us-gaap	Fair Value Disclosure Offbalance Sheet Risks Amount Asset FairValueDisclosureOffbalanceSheetRisksAmountAsset	0
CY2022	us-gaap	Revenue Recognition Interest RevenueRecognitionInterest	<div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: "Times New Roman";"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Income Recognition </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Corporate actions (including cash dividends from common stock and equity tranches of asset-backed securities) are recorded on the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ex-dividend</div> date, net of applicable withholding taxes, except for certain foreign corporate actions, which are recorded as soon after the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ex-dividend</div> date as such information becomes available. Interest income is recorded on the accrual basis. The Company does not accrue as a receivable for interest or dividends on loans, asset-backed securities and other securities if there is a reason to doubt the Company’s ability to collect such income. For loans with contractual PIK <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(payment-in-kind)</div></div> interest income, which represents contractual interest accrued and added to the loan balance that generally becomes due at maturity, we will not accrue PIK interest if we believe that the PIK interest is no longer collectible. Loan origination fees, original issue discount and market discount are capitalized and such amounts are amortized as interest income over the respective term of the loan or security. Upon the prepayment of a loan or security, any unamortized loan origination fees and original issue discount are recorded as interest income. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Accretion of discounts and amortization of premiums on taxable bonds, loans and asset-backed securities are computed to the call or maturity date, whichever is shorter, using the effective yield method. Withholding taxes on foreign dividends have been provided for in accordance with the Company’s understanding of the applicable country’s tax rules and rates. </div>
CY2021	cik0001588272	Offering Costs As A Percentage Of Total Proceeds Raised OfferingCostsAsAPercentageOfTotalProceedsRaised	0.01
CY2020	cik0001588272	Offering Costs As A Percentage Of Total Proceeds Raised OfferingCostsAsAPercentageOfTotalProceedsRaised	0.01
CY2022	cik0001588272	Offering Costs As A Percentage Of Total Proceeds Raised OfferingCostsAsAPercentageOfTotalProceedsRaised	0.01
CY2022	cik0001588272	Stock Issuance Costs StockIssuanceCosts	0
CY2021	cik0001588272	Stock Issuance Costs StockIssuanceCosts	0
CY2020	cik0001588272	Stock Issuance Costs StockIssuanceCosts	0
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	53293715
CY2022Q4	cik0001588272	Investment Owned Percentage Of Total Assets InvestmentOwnedPercentageOfTotalAssets	1
CY2022	us-gaap	Investment Company Net Assets From Operations Increase Decrease InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease	-4065174
CY2021	us-gaap	Investment Company Net Assets From Operations Increase Decrease InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease	5706143
CY2020	us-gaap	Investment Company Net Assets From Operations Increase Decrease InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease	-20899278
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9893732
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9893732
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10254666
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10254666
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10525271
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10525271
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.41
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.41
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.56
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.56
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.98
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.98
CY2022Q4	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	0.09
CY2021Q4	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	0.09
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	53293715
CY2022Q4	cik0001588272	Investment Owned Percentage Of Total Assets InvestmentOwnedPercentageOfTotalAssets	1
CY2021Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	54770694
CY2021Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	60236311
CY2021Q4	cik0001588272	Investment Owned Percentage Of Total Assets InvestmentOwnedPercentageOfTotalAssets	1
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	53293715
CY2022Q4	cik0001588272	Investment Owned Percentage Of Total Assets InvestmentOwnedPercentageOfTotalAssets	1
CY2021Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	60236311
CY2021Q4	cik0001588272	Investment Owned Percentage Of Total Assets InvestmentOwnedPercentageOfTotalAssets	1
CY2022	cik0001588272	Base Management Fee Calculated Annual Rate Of Percentage Of Average Value Of Gross Assets BaseManagementFeeCalculatedAnnualRateOfPercentageOfAverageValueOfGrossAssets	0.02
CY2022	cik0001588272	Investment Advisory Fee InvestmentAdvisoryFee	1096487
CY2021	cik0001588272	Investment Advisory Fee InvestmentAdvisoryFee	1220044
CY2020	cik0001588272	Investment Advisory Fee InvestmentAdvisoryFee	1192535
CY2022	cik0001588272	Maximum Recoupment Of Other Expenses Exceeds The Annual Rate Percentage Of Average Gross Assets MaximumRecoupmentOfOtherExpensesExceedsTheAnnualRatePercentageOfAverageGrossAssets	0.034
CY2022	cik0001588272	Subordinated Incentive Fee On Income Is Determined And Payable Quarterly In Arrears Equals Percentage Of Pre Incentive Fee Net Investment Income SubordinatedIncentiveFeeOnIncomeIsDeterminedAndPayableQuarterlyInArrearsEqualsPercentageOfPreIncentiveFeeNetInvestmentIncome	0.20
CY2022	cik0001588272	Hurdle Rate Expressed As Rate Of Return On Net Assets Equal To Percentage Per Quarter HurdleRateExpressedAsRateOfReturnOnNetAssetsEqualToPercentagePerQuarter	0.01875
CY2022	cik0001588272	Hurdle Rate HurdleRate	0.01875
CY2022Q4	cik0001588272	Pre Incentive Fee Net Investment Income For Quarter Equals Percentage Of Net Assets At The End Of Quarter PreIncentiveFeeNetInvestmentIncomeForQuarterEqualsPercentageOfNetAssetsAtTheEndOfQuarter	0.0234375
CY2022Q4	cik0001588272	Catch Up Fee Receive By The Adviser Percentage Of The Pre Incentive Fee Net Investment Income From The Quarter CatchUpFeeReceiveByTheAdviserPercentageOfThePreIncentiveFeeNetInvestmentIncomeFromTheQuarter	0.20
CY2022Q4	cik0001588272	Percentage Of Incentive Fee Capital Gains Is Determined And Payable In Arrears As At End Of Each Calender Year PercentageOfIncentiveFeeCapitalGainsIsDeterminedAndPayableInArrearsAsAtEndOfEachCalenderYear	0.20
CY2022	cik0001588272	Incentive Fee Expense On Capital Gains IncentiveFeeExpenseOnCapitalGains	0
CY2021	cik0001588272	Incentive Fee Expense On Capital Gains IncentiveFeeExpenseOnCapitalGains	0
CY2020	cik0001588272	Incentive Fee Expense On Capital Gains IncentiveFeeExpenseOnCapitalGains	0
CY2022Q4	cik0001588272	Aggregate Accrued Incentive Fees On Capital Gains AggregateAccruedIncentiveFeesOnCapitalGains	0
CY2022	cik0001588272	Payment Of Incentive Fees With Respect To Realized Gains To The Adviser PaymentOfIncentiveFeesWithRespectToRealizedGainsToTheAdviser	0
CY2022	cik0001588272	Minimum Reimbursement Amount As A Percentage Of Average Gross Assets MinimumReimbursementAmountAsAPercentageOfAverageGrossAssets	0.004
CY2022	cik0001588272	Annual Rate Percentage Of Average Gross Assets AnnualRatePercentageOfAverageGrossAssets	0.034
CY2022	cik0001588272	Organization Costs And Offering Costs Are Limited To Percentage Of Total Gross Proceeds Raised In The Offering OrganizationCostsAndOfferingCostsAreLimitedToPercentageOfTotalGrossProceedsRaisedInTheOffering	0.01
CY2022Q4	cik0001588272	Cumulative Aggregate Amount Of Organization And Offering Costs CumulativeAggregateAmountOfOrganizationAndOfferingCosts	5327574
CY2022	cik0001588272	Organization Costs And Offering Costs Are Limited To Percentage Of Total Gross Proceeds Raised In The Offering OrganizationCostsAndOfferingCostsAreLimitedToPercentageOfTotalGrossProceedsRaisedInTheOffering	0.01
CY2022	cik0001588272	Adviser Forfeited The Right To Reimbursement Of The Remaining Amount Of Costs Subsequent To Termination Of The Offering AdviserForfeitedTheRightToReimbursementOfTheRemainingAmountOfCostsSubsequentToTerminationOfTheOffering	4305091
CY2022Q4	cik0001588272	Annual Retainer Amount Payable In Quarterly Installments To Related Party Oversees All Of The Portfolios In The Fund Complex AnnualRetainerAmountPayableInQuarterlyInstallmentsToRelatedPartyOverseesAllOfThePortfoliosInTheFundComplex	150000
CY2022Q4	cik0001588272	Annual Retainer Amount Payable In Quarterly Installments To Related Party Who Does Not Oversees All Portfolios On Prorated Basis Of Who Oversees All Portfolios AnnualRetainerAmountPayableInQuarterlyInstallmentsToRelatedPartyWhoDoesNotOverseesAllPortfoliosOnProratedBasisOfWhoOverseesAllPortfolios	150000
CY2022Q4	cik0001588272	Additional Payment Amount Eligible To Receive By Related Party Payable In Quarterly Installments AdditionalPaymentAmountEligibleToReceiveByRelatedPartyPayableInQuarterlyInstallments	10000
CY2022	cik0001588272	Directors Fee Expense DirectorsFeeExpense	18170
CY2021	cik0001588272	Directors Fee Expense DirectorsFeeExpense	17781
CY2020	cik0001588272	Directors Fee Expense DirectorsFeeExpense	20123
CY2022Q4	cik0001588272	Director Fee Expense Payable Amount DirectorFeeExpensePayableAmount	0
CY2022	cik0001588272	Expense Reimbursements Amount That Are Eligible For Recoupment By The Adviser Expired ExpenseReimbursementsAmountThatAreEligibleForRecoupmentByTheAdviserExpired	147269
CY2022Q4	cik0001588272	Percentage Of Distribution To Shareholders Investment Company Taxable Income PercentageOfDistributionToShareholdersInvestmentCompanyTaxableIncome	0.90
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.98
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Disposition Of Assets EffectiveIncomeTaxRateReconciliationDispositionOfAssets	0.982
CY2022Q4	cik0001588272	Paid In Capital Excess Of Par Value PaidInCapitalExcessOfParValue	-533512
CY2021Q4	cik0001588272	Paid In Capital Excess Of Par Value PaidInCapitalExcessOfParValue	2104942
CY2020Q4	cik0001588272	Paid In Capital Excess Of Par Value PaidInCapitalExcessOfParValue	-1621021
CY2022Q4	cik0001588272	Distributions In Excess Of Net Investment Income DistributionsInExcessOfNetInvestmentIncome	-308998
CY2021Q4	cik0001588272	Distributions In Excess Of Net Investment Income DistributionsInExcessOfNetInvestmentIncome	1143870
CY2020Q4	cik0001588272	Distributions In Excess Of Net Investment Income DistributionsInExcessOfNetInvestmentIncome	1541871
CY2022Q4	cik0001588272	Accumulated Realized Gains AccumulatedRealizedGains	842510
CY2021Q4	cik0001588272	Accumulated Realized Gains AccumulatedRealizedGains	-3248812
CY2020Q4	cik0001588272	Accumulated Realized Gains AccumulatedRealizedGains	79150
CY2022Q4	us-gaap	Investment Company Distributable Earnings Loss Accumulated Ordinary Income Loss InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss	0
CY2021Q4	us-gaap	Investment Company Distributable Earnings Loss Accumulated Ordinary Income Loss InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss	72812
CY2020Q4	us-gaap	Investment Company Distributable Earnings Loss Accumulated Ordinary Income Loss InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss	687291
CY2022Q4	us-gaap	Investment Company Distributable Earnings Loss Accumulated Appreciation Depreciation InvestmentCompanyDistributableEarningsLossAccumulatedAppreciationDepreciation	-1567035
CY2021Q4	us-gaap	Investment Company Distributable Earnings Loss Accumulated Appreciation Depreciation InvestmentCompanyDistributableEarningsLossAccumulatedAppreciationDepreciation	2708891
CY2020Q4	us-gaap	Investment Company Distributable Earnings Loss Accumulated Appreciation Depreciation InvestmentCompanyDistributableEarningsLossAccumulatedAppreciationDepreciation	-6021808
CY2022Q4	us-gaap	Investment Company Distributable Earnings Loss Accumulated Long Term Capital Gain Loss InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss	0
CY2021Q4	us-gaap	Investment Company Distributable Earnings Loss Accumulated Long Term Capital Gain Loss InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss	0
CY2020Q4	us-gaap	Investment Company Distributable Earnings Loss Accumulated Long Term Capital Gain Loss InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss	0
CY2022Q4	cik0001588272	Investment Company Distributable Earnings Loss Accumulated Other Temporary Differences InvestmentCompanyDistributableEarningsLossAccumulatedOtherTemporaryDifferences	-883602
CY2021Q4	cik0001588272	Investment Company Distributable Earnings Loss Accumulated Other Temporary Differences InvestmentCompanyDistributableEarningsLossAccumulatedOtherTemporaryDifferences	-910576
CY2020Q4	cik0001588272	Investment Company Distributable Earnings Loss Accumulated Other Temporary Differences InvestmentCompanyDistributableEarningsLossAccumulatedOtherTemporaryDifferences	1315827
CY2022Q4	us-gaap	Investment Company Distributable Earnings Loss Accumulated Capital Loss Carryforward InvestmentCompanyDistributableEarningsLossAccumulatedCapitalLossCarryforward	30814250
CY2021Q4	us-gaap	Investment Company Distributable Earnings Loss Accumulated Capital Loss Carryforward InvestmentCompanyDistributableEarningsLossAccumulatedCapitalLossCarryforward	30077894
CY2020Q4	us-gaap	Investment Company Distributable Earnings Loss Accumulated Capital Loss Carryforward InvestmentCompanyDistributableEarningsLossAccumulatedCapitalLossCarryforward	24156099
CY2022	us-gaap	Investment Company Dividend Distribution InvestmentCompanyDividendDistribution	1526458
CY2021	us-gaap	Investment Company Dividend Distribution InvestmentCompanyDividendDistribution	3633179
CY2020	us-gaap	Investment Company Dividend Distribution InvestmentCompanyDividendDistribution	4409400
CY2022	us-gaap	Investment Company Tax Return Of Capital Distribution InvestmentCompanyTaxReturnOfCapitalDistribution	1999373
CY2021	us-gaap	Investment Company Tax Return Of Capital Distribution InvestmentCompanyTaxReturnOfCapitalDistribution	0
CY2020	us-gaap	Investment Company Tax Return Of Capital Distribution InvestmentCompanyTaxReturnOfCapitalDistribution	0
CY2022	cik0001588272	Investment Company Long Term Gain InvestmentCompanyLongTermGain	0
CY2021	cik0001588272	Investment Company Long Term Gain InvestmentCompanyLongTermGain	0
CY2020	cik0001588272	Investment Company Long Term Gain InvestmentCompanyLongTermGain	0
CY2022Q4	us-gaap	Tax Basis Of Investments Gross Unrealized Appreciation TaxBasisOfInvestmentsGrossUnrealizedAppreciation	7373938
CY2022Q4	us-gaap	Tax Basis Of Investments Gross Unrealized Depreciation TaxBasisOfInvestmentsGrossUnrealizedDepreciation	8940973
CY2022Q4	us-gaap	Tax Basis Of Investments Unrealized Appreciation Depreciation Net TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet	-1567035
CY2022Q4	us-gaap	Tax Basis Of Investments Cost For Income Tax Purposes TaxBasisOfInvestmentsCostForIncomeTaxPurposes	54860750
CY2021Q4	us-gaap	Tax Basis Of Investments Gross Unrealized Appreciation TaxBasisOfInvestmentsGrossUnrealizedAppreciation	4599564
CY2021Q4	us-gaap	Tax Basis Of Investments Gross Unrealized Depreciation TaxBasisOfInvestmentsGrossUnrealizedDepreciation	1890673
CY2021Q4	us-gaap	Tax Basis Of Investments Unrealized Appreciation Depreciation Net TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet	2708891
CY2021Q4	us-gaap	Tax Basis Of Investments Cost For Income Tax Purposes TaxBasisOfInvestmentsCostForIncomeTaxPurposes	57527420
CY2020Q4	us-gaap	Tax Basis Of Investments Gross Unrealized Appreciation TaxBasisOfInvestmentsGrossUnrealizedAppreciation	7723451
CY2020Q4	us-gaap	Tax Basis Of Investments Gross Unrealized Depreciation TaxBasisOfInvestmentsGrossUnrealizedDepreciation	13745259
CY2020Q4	us-gaap	Tax Basis Of Investments Unrealized Appreciation Depreciation Net TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet	-6021808
CY2020Q4	us-gaap	Tax Basis Of Investments Cost For Income Tax Purposes TaxBasisOfInvestmentsCostForIncomeTaxPurposes	70690423
CY2022	cik0001588272	Share Repurchase Program ShareRepurchaseProgram	<div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: "Times New Roman";"><div style="font-weight:bold;display:inline;">Note 6 — Share Repurchase Program </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On a quarterly basis, the Company intends to offer to repurchase shares of common stock on such terms as may be determined by the Board in its complete and absolute discretion unless, in the judgment of directors who are not “interested persons” of the Company (as defined in the 1940 Act), such repurchases would not be in the best interests of the Company’s stockholders or would violate applicable law. The Company will conduct such repurchase offers in accordance with the requirements of Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">13e-4</div> of the Exchange Act, and the 1940 Act. Any offer to repurchase shares of common stock will be conducted solely through tender offer materials furnished to each stockholder. </div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company currently intends to limit the number of shares of common stock to be repurchased during any calendar year to the number of shares of common stock it can repurchase with the proceeds it receives from the sale of shares of common stock under its distribution reinvestment plan. At the discretion of the Board, the Company may also use cash on hand, cash available from borrowings and cash from liquidation of securities investments as of the end of the applicable period to repurchase shares of common stock. In addition, the Company will limit the number of shares of common stock to be repurchased in any calendar year to 10.0% of the weighted average number of shares of common stock outstanding in the prior calendar year, or 2.5% in each quarter, though the actual number of shares of common stock that the Company offers to repurchase may be less in light of the limitations noted above. The Company intends to offer to repurchase such shares of common stock at a price (i) not less than the net asset value per share (the “NAV Per Share”) of the Company’s common stock next calculated following the Expiration Date, and (ii) not more than 2.5% greater than the NAV Per Share as of such date. The Board may amend, suspend or terminate the share repurchase program at any time, upon 30 days’ notice. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company conducted its quarterly tender offer for the first quarter of 2022 from February 23, 2022, until expiration of March 23, 2022 at 4:00 p.m. New York City time, during which the Company offered to purchase for cash up to 2.5% of its outstanding shares of common stock. During the first quarter tender offer, 85,999 shares of the Company were tendered for repurchase, constituting approximately 0.86% of the Company’s outstanding shares. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company conducted its quarterly tender offer for the second quarter of 2022 from May 20, 2022, until expiration of June 21, 2022 at 4:00 p.m. New York City time, during which the Company offered to purchase for cash up to 2.5% of its outstanding shares of common stock. During the second quarter tender offer, 102,662 shares of the Company were tendered for repurchase,constituting approximately 1.03% of the Company’s outstanding shares. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company conducted its quarterly tender offer for the third quarter of 2022 from August 19, 2022, until expiration of September 19,2022 at 4:00 p.m. New York City time, during which the Company offered to purchase for cash up to 2.5% of its outstanding shares of common stock. During the third quarter tender offer, 195,785 shares of the Company were tendered for repurchase, constituting approximately 1.97% of the Company’s outstanding shares. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company conducted its quarterly tender offer for the fourth quarter of 2022 from November 18, 2022, until expiration of December 19, 2022 at 4:00p.m. New York City time, during which the Company offered to purchase for cash up to 2.5% of its outstanding shares of common stock. During the fourth quarter tender offer, 94,263 shares of the Company were tendered for repurchase, constituting approximately 0.95% of the Company’s outstanding shares. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the year ended December 31, 2022, the Company repurchased 0 shares as part of its death and disability repurchase program. </div>
CY2022Q4	cik0001588272	Minimum Limit Of Shares To Be Repurchased Percent MinimumLimitOfSharesToBeRepurchasedPercent	0.10
CY2022Q1	cik0001588272	Minimum Limit Of Shares To Be Repurchased Percent MinimumLimitOfSharesToBeRepurchasedPercent	0.025
CY2022Q4	cik0001588272	Percentage Of Shares To Be Issued Under Ceiling Limit Of Net Asset Value Per Share PercentageOfSharesToBeIssuedUnderCeilingLimitOfNetAssetValuePerShare	0.025
CY2022Q4	cik0001588272	Minimum Notice Period Of Shares To Be Suspend Or Terminate MinimumNoticePeriodOfSharesToBeSuspendOrTerminate	0.30
CY2022	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0
CY2022	cik0001588272	Investment Company Direct Interest Expense InvestmentCompanyDirectInterestExpense	0
CY2021	cik0001588272	Investment Company Direct Interest Expense InvestmentCompanyDirectInterestExpense	0
CY2020	cik0001588272	Investment Company Direct Interest Expense InvestmentCompanyDirectInterestExpense	176911
CY2022	cik0001588272	Investment Company Commitment Fees InvestmentCompanyCommitmentFees	0
CY2021	cik0001588272	Investment Company Commitment Fees InvestmentCompanyCommitmentFees	0
CY2020	cik0001588272	Investment Company Commitment Fees InvestmentCompanyCommitmentFees	204
CY2022	cik0001588272	Investment Company Amortization Of Financing Costs InvestmentCompanyAmortizationOfFinancingCosts	0
CY2021	cik0001588272	Investment Company Amortization Of Financing Costs InvestmentCompanyAmortizationOfFinancingCosts	0
CY2020	cik0001588272	Investment Company Amortization Of Financing Costs InvestmentCompanyAmortizationOfFinancingCosts	0
CY2022	us-gaap	Interest Expense InterestExpense	0
CY2021	us-gaap	Interest Expense InterestExpense	0
CY2020	us-gaap	Interest Expense InterestExpense	176707
CY2022	us-gaap	Liabilities Average Amount Outstanding LiabilitiesAverageAmountOutstanding	0
CY2021	us-gaap	Liabilities Average Amount Outstanding LiabilitiesAverageAmountOutstanding	0
CY2020	us-gaap	Liabilities Average Amount Outstanding LiabilitiesAverageAmountOutstanding	22670341
CY2022	us-gaap	Long Term Debt Weighted Average Interest Rate Over Time LongTermDebtWeightedAverageInterestRateOverTime	0
CY2021	us-gaap	Long Term Debt Weighted Average Interest Rate Over Time LongTermDebtWeightedAverageInterestRateOverTime	0
CY2020	us-gaap	Long Term Debt Weighted Average Interest Rate Over Time LongTermDebtWeightedAverageInterestRateOverTime	0.0267
CY2022Q4	cik0001588272	Minimum Percentage Of Asset Coverage For Borrowing MinimumPercentageOfAssetCoverageForBorrowing	2
CY2022	us-gaap	Line Of Credit Facility Maximum Amount Outstanding During Period LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod	0
CY2022	cik0001588272	Percentage Of Asset Coverage PercentageOfAssetCoverage	0
CY2021	us-gaap	Line Of Credit Facility Maximum Amount Outstanding During Period LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod	0
CY2021	cik0001588272	Percentage Of Asset Coverage PercentageOfAssetCoverage	0
CY2020	us-gaap	Line Of Credit Facility Maximum Amount Outstanding During Period LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod	0
CY2020	cik0001588272	Percentage Of Asset Coverage PercentageOfAssetCoverage	0
CY2019	us-gaap	Line Of Credit Facility Maximum Amount Outstanding During Period LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod	63219694
CY2019	cik0001588272	Percentage Of Asset Coverage PercentageOfAssetCoverage	2.41
CY2018	us-gaap	Line Of Credit Facility Maximum Amount Outstanding During Period LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod	67767021
CY2018	cik0001588272	Percentage Of Asset Coverage PercentageOfAssetCoverage	2.27
CY2017	us-gaap	Line Of Credit Facility Maximum Amount Outstanding During Period LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod	46540921
CY2017	cik0001588272	Percentage Of Asset Coverage PercentageOfAssetCoverage	3.04
CY2016	us-gaap	Line Of Credit Facility Maximum Amount Outstanding During Period LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod	11200000
CY2016	cik0001588272	Percentage Of Asset Coverage PercentageOfAssetCoverage	7.01
CY2015	us-gaap	Line Of Credit Facility Maximum Amount Outstanding During Period LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod	0
CY2014	us-gaap	Line Of Credit Facility Maximum Amount Outstanding During Period LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod	0
CY2021Q4	us-gaap	Investments In And Advances To Affiliates Balance Shares InvestmentsInAndAdvancesToAffiliatesBalanceShares	5338804
CY2021Q4	us-gaap	Investments In And Advances To Affiliates At Fair Value InvestmentsInAndAdvancesToAffiliatesAtFairValue	12778650
CY2022	us-gaap	Investments In And Advances To Affiliates At Fair Value Period Increase Decrease InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease	0
CY2022	us-gaap	Investments In And Advances To Affiliates At Fair Value Gross Additions InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions	7781218
CY2022	us-gaap	Investments In And Advances To Affiliates At Fair Value Gross Reductions InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossReductions	8113079
CY2022	cik0001588272	Investments In And Advances To Affiliates At Fair Value Realized Gains Losses InvestmentsInAndAdvancesToAffiliatesAtFairValueRealizedGainsLosses	262564
CY2022	cik0001588272	Investments In And Advances To Affiliates At Fair Value Changein Unrealized Appreciation Depreciation InvestmentsInAndAdvancesToAffiliatesAtFairValueChangeinUnrealizedAppreciationDepreciation	-2436352
CY2022Q4	us-gaap	Investments In And Advances To Affiliates At Fair Value InvestmentsInAndAdvancesToAffiliatesAtFairValue	10273001
CY2022Q4	us-gaap	Investments In And Advances To Affiliates Balance Shares InvestmentsInAndAdvancesToAffiliatesBalanceShares	956291
CY2022	us-gaap	Investments In And Advances To Affiliates Dividends Or Interest InvestmentsInAndAdvancesToAffiliatesDividendsOrInterest	675057
CY2021Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	6.32
CY2020Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	6.13
CY2019Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	8.53
CY2018Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	8.36
CY2017Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	9.68
CY2022	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	0.18
CY2021	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	0.19
CY2020	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	0.24
CY2019	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	0.3
CY2018	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	0.36
CY2022	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	-0.59
CY2021	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	0.37
CY2020	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	-2.22
CY2019	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	0.59
CY2018	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	-0.96
CY2022	us-gaap	Investment Company Investment Income Loss From Operations Per Share InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare	-0.41
CY2021	us-gaap	Investment Company Investment Income Loss From Operations Per Share InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare	0.56
CY2020	us-gaap	Investment Company Investment Income Loss From Operations Per Share InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare	-1.98
CY2019	us-gaap	Investment Company Investment Income Loss From Operations Per Share InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare	0.89
CY2018	us-gaap	Investment Company Investment Income Loss From Operations Per Share InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare	-0.6
CY2022	cik0001588272	Investment Companyfrom Net Investment Income Per Share InvestmentCompanyfromNetInvestmentIncomePerShare	-0.16
CY2021	cik0001588272	Investment Companyfrom Net Investment Income Per Share InvestmentCompanyfromNetInvestmentIncomePerShare	-0.37
CY2020	cik0001588272	Investment Companyfrom Net Investment Income Per Share InvestmentCompanyfromNetInvestmentIncomePerShare	-0.42
CY2019	cik0001588272	Investment Companyfrom Net Investment Income Per Share InvestmentCompanyfromNetInvestmentIncomePerShare	-0.6
CY2018	cik0001588272	Investment Companyfrom Net Investment Income Per Share InvestmentCompanyfromNetInvestmentIncomePerShare	-0.73
CY2022	cik0001588272	Investment Company From Net Realized Gains Per Share InvestmentCompanyFromNetRealizedGainsPerShare	0
CY2021	cik0001588272	Investment Company From Net Realized Gains Per Share InvestmentCompanyFromNetRealizedGainsPerShare	0
CY2020	cik0001588272	Investment Company From Net Realized Gains Per Share InvestmentCompanyFromNetRealizedGainsPerShare	0
CY2019	cik0001588272	Investment Company From Net Realized Gains Per Share InvestmentCompanyFromNetRealizedGainsPerShare	-0.12
CY2018	cik0001588272	Investment Company From Net Realized Gains Per Share InvestmentCompanyFromNetRealizedGainsPerShare	0
CY2022	cik0001588272	Investment Companyfrom Return Of Capital Per Share InvestmentCompanyfromReturnOfCapitalPerShare	-0.2
CY2021	cik0001588272	Investment Companyfrom Return Of Capital Per Share InvestmentCompanyfromReturnOfCapitalPerShare	0
CY2020	cik0001588272	Investment Companyfrom Return Of Capital Per Share InvestmentCompanyfromReturnOfCapitalPerShare	0
CY2019	cik0001588272	Investment Companyfrom Return Of Capital Per Share InvestmentCompanyfromReturnOfCapitalPerShare	0
CY2018	cik0001588272	Investment Companyfrom Return Of Capital Per Share InvestmentCompanyfromReturnOfCapitalPerShare	0
CY2022	cik0001588272	Distributions Declared To Common Shareholders DistributionsDeclaredToCommonShareholders	0.36
CY2021	cik0001588272	Distributions Declared To Common Shareholders DistributionsDeclaredToCommonShareholders	0.37
CY2020	cik0001588272	Distributions Declared To Common Shareholders DistributionsDeclaredToCommonShareholders	0.42
CY2019	cik0001588272	Distributions Declared To Common Shareholders DistributionsDeclaredToCommonShareholders	0.72
CY2018	cik0001588272	Distributions Declared To Common Shareholders DistributionsDeclaredToCommonShareholders	0.73
CY2022	cik0001588272	Investment Companyissuance Of Common Stock Per Share InvestmentCompanyissuanceOfCommonStockPerShare	0
CY2021	cik0001588272	Investment Companyissuance Of Common Stock Per Share InvestmentCompanyissuanceOfCommonStockPerShare	0
CY2020	cik0001588272	Investment Companyissuance Of Common Stock Per Share InvestmentCompanyissuanceOfCommonStockPerShare	0
CY2019	cik0001588272	Investment Companyissuance Of Common Stock Per Share InvestmentCompanyissuanceOfCommonStockPerShare	0
CY2018	cik0001588272	Investment Companyissuance Of Common Stock Per Share InvestmentCompanyissuanceOfCommonStockPerShare	0.01
CY2022	cik0001588272	Investment Companyshares Tendered Per Share InvestmentCompanysharesTenderedPerShare	0
CY2021	cik0001588272	Investment Companyshares Tendered Per Share InvestmentCompanysharesTenderedPerShare	0
CY2020	cik0001588272	Investment Companyshares Tendered Per Share InvestmentCompanysharesTenderedPerShare	0
CY2019	cik0001588272	Investment Companyshares Tendered Per Share InvestmentCompanysharesTenderedPerShare	0
CY2018	cik0001588272	Investment Companyshares Tendered Per Share InvestmentCompanysharesTenderedPerShare	0
CY2022Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	5.55
CY2021Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	6.32
CY2020Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	6.13
CY2019Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	8.53
CY2018Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	8.36
CY2022	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	-0.0665
CY2021	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.0912
CY2020	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	-0.2317
CY2019	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.1086
CY2018	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	-0.0675
CY2022Q4	us-gaap	Assets Net AssetsNet	53694000
CY2021Q4	us-gaap	Assets Net AssetsNet	62939000
CY2020Q4	us-gaap	Assets Net AssetsNet	64190000
CY2019Q4	us-gaap	Assets Net AssetsNet	88936000
CY2018Q4	us-gaap	Assets Net AssetsNet	86311000
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9677593
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9956228
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10475168
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10425431
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10322327
CY2022	us-gaap	Investment Company Investment Income Loss Ratio InvestmentCompanyInvestmentIncomeLossRatio	0.0382
CY2021	us-gaap	Investment Company Investment Income Loss Ratio InvestmentCompanyInvestmentIncomeLossRatio	0.0378
CY2020	us-gaap	Investment Company Investment Income Loss Ratio InvestmentCompanyInvestmentIncomeLossRatio	0.0399
CY2019	us-gaap	Investment Company Investment Income Loss Ratio InvestmentCompanyInvestmentIncomeLossRatio	0.0536
CY2018	us-gaap	Investment Company Investment Income Loss Ratio InvestmentCompanyInvestmentIncomeLossRatio	0.0432
CY2022	us-gaap	Investment Company Expense Ratio Voluntary Fee Waiver InvestmentCompanyExpenseRatioVoluntaryFeeWaiver	0.0063
CY2021	us-gaap	Investment Company Expense Ratio Voluntary Fee Waiver InvestmentCompanyExpenseRatioVoluntaryFeeWaiver	0.0045
CY2020	us-gaap	Investment Company Expense Ratio Voluntary Fee Waiver InvestmentCompanyExpenseRatioVoluntaryFeeWaiver	0.0054
CY2019	us-gaap	Investment Company Expense Ratio Voluntary Fee Waiver InvestmentCompanyExpenseRatioVoluntaryFeeWaiver	0.0016
CY2018	us-gaap	Investment Company Expense Ratio Voluntary Fee Waiver InvestmentCompanyExpenseRatioVoluntaryFeeWaiver	0.0043
CY2022	us-gaap	Investment Company Expense Ratio Including Voluntary Fee Waiver InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver	0.0319
CY2021	us-gaap	Investment Company Expense Ratio Including Voluntary Fee Waiver InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver	0.0333
CY2020	us-gaap	Investment Company Expense Ratio Including Voluntary Fee Waiver InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver	0.0345
CY2019	us-gaap	Investment Company Expense Ratio Including Voluntary Fee Waiver InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver	0.052
CY2018	us-gaap	Investment Company Expense Ratio Including Voluntary Fee Waiver InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver	0.0389
CY2022	us-gaap	Investment Company Investment Income Loss Ratio Before Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioBeforeIncentiveAllocation	0.0243
CY2021	us-gaap	Investment Company Investment Income Loss Ratio Before Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioBeforeIncentiveAllocation	0.025
CY2020	us-gaap	Investment Company Investment Income Loss Ratio Before Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioBeforeIncentiveAllocation	0.0341
CY2019	us-gaap	Investment Company Investment Income Loss Ratio Before Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioBeforeIncentiveAllocation	0.0333
CY2018	us-gaap	Investment Company Investment Income Loss Ratio Before Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioBeforeIncentiveAllocation	0.0328
CY2022	us-gaap	Investment Company Investment Income Loss Ratio After Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation	0.0306
CY2021	us-gaap	Investment Company Investment Income Loss Ratio After Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation	0.0295
CY2020	us-gaap	Investment Company Investment Income Loss Ratio After Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation	0.0395
CY2019	us-gaap	Investment Company Investment Income Loss Ratio After Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation	0.035
CY2018	us-gaap	Investment Company Investment Income Loss Ratio After Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation	0.0371
CY2022	cik0001588272	Investment Company Credit Facility Expenses To Average Net Assets InvestmentCompanyCreditFacilityExpensesToAverageNetAssets	0
CY2021	cik0001588272	Investment Company Credit Facility Expenses To Average Net Assets InvestmentCompanyCreditFacilityExpensesToAverageNetAssets	0
CY2020	cik0001588272	Investment Company Credit Facility Expenses To Average Net Assets InvestmentCompanyCreditFacilityExpensesToAverageNetAssets	0.0027
CY2019	cik0001588272	Investment Company Credit Facility Expenses To Average Net Assets InvestmentCompanyCreditFacilityExpensesToAverageNetAssets	0.0137
CY2018	cik0001588272	Investment Company Credit Facility Expenses To Average Net Assets InvestmentCompanyCreditFacilityExpensesToAverageNetAssets	0.0076
CY2022	cik0001588272	Ratio Of Incentive Fees To Average Net Assets RatioOfIncentiveFeesToAverageNetAssets	0
CY2021	cik0001588272	Ratio Of Incentive Fees To Average Net Assets RatioOfIncentiveFeesToAverageNetAssets	0
CY2020	cik0001588272	Ratio Of Incentive Fees To Average Net Assets RatioOfIncentiveFeesToAverageNetAssets	0
CY2019	cik0001588272	Ratio Of Incentive Fees To Average Net Assets RatioOfIncentiveFeesToAverageNetAssets	0
CY2018	cik0001588272	Ratio Of Incentive Fees To Average Net Assets RatioOfIncentiveFeesToAverageNetAssets	-0.006
CY2022	cik0001588272	Investment Companyportfolio Turnover Rate InvestmentCompanyportfolioTurnoverRate	0.16
CY2021	cik0001588272	Investment Companyportfolio Turnover Rate InvestmentCompanyportfolioTurnoverRate	0.13
CY2020	cik0001588272	Investment Companyportfolio Turnover Rate InvestmentCompanyportfolioTurnoverRate	0.83
CY2019	cik0001588272	Investment Companyportfolio Turnover Rate InvestmentCompanyportfolioTurnoverRate	0.42
CY2018	cik0001588272	Investment Companyportfolio Turnover Rate InvestmentCompanyportfolioTurnoverRate	0.55
CY2022	cik0001588272	Investment Companyasset Coverage Ratio InvestmentCompanyassetCoverageRatio	0
CY2021	cik0001588272	Investment Companyasset Coverage Ratio InvestmentCompanyassetCoverageRatio	0
CY2020	cik0001588272	Investment Companyasset Coverage Ratio InvestmentCompanyassetCoverageRatio	0
CY2019	cik0001588272	Investment Companyasset Coverage Ratio InvestmentCompanyassetCoverageRatio	2.41
CY2018	cik0001588272	Investment Companyasset Coverage Ratio InvestmentCompanyassetCoverageRatio	2.27
CY2022	us-gaap	Investment Company Incentive Fee To Average Net Assets InvestmentCompanyIncentiveFeeToAverageNetAssets	0
CY2021	us-gaap	Investment Company Incentive Fee To Average Net Assets InvestmentCompanyIncentiveFeeToAverageNetAssets	0
CY2020	us-gaap	Investment Company Incentive Fee To Average Net Assets InvestmentCompanyIncentiveFeeToAverageNetAssets	0.000328
CY2019	us-gaap	Investment Company Incentive Fee To Average Net Assets InvestmentCompanyIncentiveFeeToAverageNetAssets	0.000331
CY2018	us-gaap	Investment Company Incentive Fee To Average Net Assets InvestmentCompanyIncentiveFeeToAverageNetAssets	0.00038
CY2022Q4	cik0001588272	Investment Company Investment Income Total InvestmentCompanyInvestmentIncomeTotal	584515
CY2022Q3	cik0001588272	Investment Company Investment Income Total InvestmentCompanyInvestmentIncomeTotal	993592
CY2022Q2	cik0001588272	Investment Company Investment Income Total InvestmentCompanyInvestmentIncomeTotal	1099896
CY2022Q1	cik0001588272	Investment Company Investment Income Total InvestmentCompanyInvestmentIncomeTotal	1014610
CY2022Q4	cik0001588272	Investment Company Investment Income Loss Per Share Gross InvestmentCompanyInvestmentIncomeLossPerShareGross	0.06
CY2022Q3	cik0001588272	Investment Company Investment Income Loss Per Share Gross InvestmentCompanyInvestmentIncomeLossPerShareGross	0.1
CY2022Q2	cik0001588272	Investment Company Investment Income Loss Per Share Gross InvestmentCompanyInvestmentIncomeLossPerShareGross	0.11
CY2022Q1	cik0001588272	Investment Company Investment Income Loss Per Share Gross InvestmentCompanyInvestmentIncomeLossPerShareGross	0.1
CY2022Q4	us-gaap	Net Investment Income NetInvestmentIncome	113631
CY2022Q3	us-gaap	Net Investment Income NetInvestmentIncome	555608
CY2022Q2	us-gaap	Net Investment Income NetInvestmentIncome	629257
CY2022Q1	us-gaap	Net Investment Income NetInvestmentIncome	491122
CY2022Q4	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	0.01
CY2022Q3	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	0.06
CY2022Q2	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	0.06
CY2022Q1	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	0.05
CY2022Q4	cik0001588272	Investment Company Gain Loss On Investment InvestmentCompanyGainLossOnInvestment	257082
CY2022Q3	cik0001588272	Investment Company Gain Loss On Investment InvestmentCompanyGainLossOnInvestment	-3208231
CY2022Q2	cik0001588272	Investment Company Gain Loss On Investment InvestmentCompanyGainLossOnInvestment	-3557538
CY2022Q1	cik0001588272	Investment Company Gain Loss On Investment InvestmentCompanyGainLossOnInvestment	653895
CY2022Q4	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	0.03
CY2022Q3	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	-0.32
CY2022Q2	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	-0.36
CY2022Q1	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	0.07
CY2022Q4	us-gaap	Investment Company Net Assets From Operations Increase Decrease InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease	370713
CY2022Q3	us-gaap	Investment Company Net Assets From Operations Increase Decrease InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease	-2652623
CY2022Q2	us-gaap	Investment Company Net Assets From Operations Increase Decrease InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease	-2928281
CY2022Q1	us-gaap	Investment Company Net Assets From Operations Increase Decrease InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease	1145017
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.27
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.27
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.29
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.29
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.11
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.11
CY2022Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	5.55
CY2022Q3	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	5.6
CY2022Q2	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	5.96
CY2022Q1	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	6.35
CY2021Q4	cik0001588272	Investment Company Investment Income Total InvestmentCompanyInvestmentIncomeTotal	568465
CY2021Q3	cik0001588272	Investment Company Investment Income Total InvestmentCompanyInvestmentIncomeTotal	1374141
CY2021Q2	cik0001588272	Investment Company Investment Income Total InvestmentCompanyInvestmentIncomeTotal	1047775
CY2021Q1	cik0001588272	Investment Company Investment Income Total InvestmentCompanyInvestmentIncomeTotal	1107478
CY2021Q4	cik0001588272	Investment Company Investment Income Loss Per Share Gross InvestmentCompanyInvestmentIncomeLossPerShareGross	0.06
CY2021Q3	cik0001588272	Investment Company Investment Income Loss Per Share Gross InvestmentCompanyInvestmentIncomeLossPerShareGross	0.13
CY2021Q2	cik0001588272	Investment Company Investment Income Loss Per Share Gross InvestmentCompanyInvestmentIncomeLossPerShareGross	0.1
CY2021Q1	cik0001588272	Investment Company Investment Income Loss Per Share Gross InvestmentCompanyInvestmentIncomeLossPerShareGross	0.1
CY2021Q4	us-gaap	Net Investment Income NetInvestmentIncome	-2205
CY2021Q3	us-gaap	Net Investment Income NetInvestmentIncome	846923
CY2021Q2	us-gaap	Net Investment Income NetInvestmentIncome	534156
CY2021Q1	us-gaap	Net Investment Income NetInvestmentIncome	544553
CY2021Q4	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	0.01
CY2021Q3	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	0.08
CY2021Q2	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	0.05
CY2021Q1	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	0.05
CY2021Q4	cik0001588272	Investment Company Gain Loss On Investment InvestmentCompanyGainLossOnInvestment	133319
CY2021Q3	cik0001588272	Investment Company Gain Loss On Investment InvestmentCompanyGainLossOnInvestment	-865376
CY2021Q2	cik0001588272	Investment Company Gain Loss On Investment InvestmentCompanyGainLossOnInvestment	2785269
CY2021Q1	cik0001588272	Investment Company Gain Loss On Investment InvestmentCompanyGainLossOnInvestment	1729504
CY2021Q4	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	0.01
CY2021Q3	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	-0.08
CY2021Q2	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	0.27
CY2021Q1	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	0.17
CY2021Q4	us-gaap	Investment Company Net Assets From Operations Increase Decrease InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease	131114
CY2021Q3	us-gaap	Investment Company Net Assets From Operations Increase Decrease InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease	-18453
CY2021Q2	us-gaap	Investment Company Net Assets From Operations Increase Decrease InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease	3319425
CY2021Q1	us-gaap	Investment Company Net Assets From Operations Increase Decrease InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease	2274057
CY2021Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2021Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.32
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.32
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.22
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.22
CY2021Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	6.32
CY2021Q3	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	6.4
CY2021Q2	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	6.49
CY2021Q1	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	6.25
CY2022	dei	Auditor Name AuditorName	COHEN & COMPANY, LTD.
CY2022	dei	Auditor Location AuditorLocation	Cleveland, Ohio
CY2022	dei	Auditor Firm AuditorFirmId	925

Files In Submission

Name	View Source	Status
0001193125-23-079332-index-headers.html	Edgar Link	pending
0001193125-23-079332-index.html	Edgar Link	pending
0001193125-23-079332.txt	Edgar Link	pending
0001193125-23-079332-xbrl.zip	Edgar Link	pending
cik0001588272-20221231.xsd	Edgar Link	pending
cik0001588272-20221231_cal.xml	Edgar Link	unprocessable
d437941d10k.htm	Edgar Link	pending
d437941dex311.htm	Edgar Link	pending
d437941dex312.htm	Edgar Link	pending
d437941dex321.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
g437941g0324042458987.jpg	Edgar Link	pending
g437941g21a79.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
cik0001588272-20221231_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
d437941d10k_htm.xml	Edgar Link	completed
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cik0001588272-20221231_lab.xml	Edgar Link	unprocessable
cik0001588272-20221231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NXPT
Nexpoint Capital Inc Stock $nxpt

2022 Q4 Form 10-K Financial Statement

#000119312523079332 Filed on March 27, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NXPT Nexpoint Capital Inc Stock $nxpt

2022 Q4 Form 10-K Financial Statement

#000119312523079332 Filed on March 27, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NXPT
Nexpoint Capital Inc Stock $nxpt